Trial Profile
Phase III trial of avibactam/ceftazidime
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 29 Dec 2009
Price :
$35
*
At a glance
- Drugs Avibactam/ceftazidime (Primary)
- Indications Gram-negative infections; Intra-abdominal infections; Urinary tract infections
- Focus Therapeutic Use
- Sponsors AstraZeneca; Novexel
- 29 Dec 2009 New trial record